Spots Global Cancer Trial Database for The Comparison Between Computed Tomography and Colonoscope in Detecting Colorectal Tumors in Patients With FIT+

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Comparison Between Computed Tomography and Colonoscope in Detecting Colorectal Tumors in Patients With FIT+

Official Title: The Comparison of Diagnostic Yield Between Routine Computed Tomography and Colonoscope in Detecting Colorectal Tumors in Patients Who at Risk of Colorectal Cancer

Study ID: NCT06165328

Conditions

Patients at Risk of Colorectal Cancer

Interventions

CT and colonoscopy

Study Description

Brief Summary: Colonoscopy is the mainstay modality of choice in colorectal cancer screening worldwide. However, the rate of colonoscopy for colorectal cancer screening is very low (approximately 5-10%) because of the limited local medical resources (such as endoscopists and regional endoscope). This observational diagnostic test study aims to compare the diagnostic yield of routine computed tomography and colonoscopy in detecting colorectal tumors in patients at risk of colorectal cancer (aged more than 50 years and FIT+). The main question\[s\] it aims to answer are: 1. To compare the diagnostic yield between the routine computed tomography and colonoscopy. 2. To compare the procedure-related adverse events between the routine computed tomography and colonoscopy.

Detailed Description: All enrolled patients underwent routine CT scans of whole abdomen, then subsequently under went a colonoscopy on the next day